All News

Susan G.Komen-Greater NYC announced today the members of its newly appointed Medical Advisory Committee.

Sometimes it takes a bigger candle to shine a light on our disease.

The PAN Foundation today opened a new patient assistance program for people living with Waldenstrom macroglobulinemia, a rare type of blood cancer that originates in the lymphatic system and is characterized by an excess of abnormal white blood cells and proteins called immunoglobulins.

Many patients suffer from chronic pain, making opioids essential for care.

While novel agents continue to evolve in the treatment landscape for chronic lymphocytic leukemia, many may start to be combined in the front-line setting as well, according to Matthew S. Davids, M.D., MMSc.

As much as patients look forward to the day they can ring the bell or hear they have no evidence of disease, it can also mean they will be sent out on their own to sort through life with the long-term damage of cancer.

Liquid biopsies may be less invasive and faster in determining the genetics of a tumor — and with high accuracy — among those diagnosed with non-small cell lung cancer.

The National Community Oncology Dispensing Association, Inc. (NCODA) is pleased to announce the addition of three new members to the Executive Council.

Here are the top 5 CURE stories for March 2019.

This week, the Food and Drug Administration (FDA) proposed changes to improve and modernize breast cancer screening. In their proposal, the FDA submitted amendments to the current regulations that would provide patients with more detailed information. This information, which would include breast density, would help patients make better decisions regarding their personal health care.

Though narrowly defeated in the Maryland Senate, versions of similar bills are being considered in other states. If these bills pass, what will become of end-of-life care?

Despite emotional testimony from women who say their breast implants made them sick with cancer or autoimmune symptoms, the Food and Drug Administration (FDA) has no plans to ban the textured implants that are being blamed.

From professional athletes to an FDA Breakthrough Therapy designation, here’s what is making headlines in the cancer space this week.

Support is essential for cancer survivors, especially as we struggle to reintegrate into our lives.

Dana-Farber Cancer Institute opens the first-ever Lynch Syndrome Center to help patients and families with the inherited condition.

The FDA announced on March 27, 2019 that it is working to update mammography regulations, expanding the amount of information that mammography facilities must give patients and healthcare professionals.

Everyone will go through a tough time or a trauma in their life. You need a go-to list of items you can latch onto to help you through it.

Three sisters trace their family’s experiences with breast and ovarian cancer across generations.

By the time 14 months of treatment were through, I was watching a woman I no longer recognized and could not bear to look at in the mirror. I realized that to truly be a survivor, I had to readjust my expectations of myself.

Barriers to treatment can be an uphill battle for patients with cancer; however, one company is here to help.

It’s hard to let go of fear when that’s all you feel. It’s called rumination. The trick is finding ways to stop ruminating about the fear to be able to live fully until whatever is going to happen, happens.

Mike Hennessy, Sr., Chairman and CEO, discusses psychosocial issues associated with women's cancers — the mental, emotional, social and spiritual effects of cancer that occur at diagnosis, during treatment and throughout life after the disease.

Family and friends receive the cancer diagnosis right along with the patient. People change, relationships change and life as you know it may never be the same.

We all have our angels here on earth, but need to know where to find them (and be one) on our difficult cancer journey.

Enormous progress has been made in breast cancer, yet many challenges remain, according to Ann H. Partridge, M.D., MPH.

Administration of Opdivo (nivolumab) before surgical resection in patients with glioblastoma appeared safe and feasible, according to phase 2 trial results published in Nature Medicine.